miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605493/
https://www.ncbi.nlm.nih.gov/pubmed/33149576
http://dx.doi.org/10.2147/IJN.S287784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605493/
https://www.ncbi.nlm.nih.gov/pubmed/33149576
http://dx.doi.org/10.2147/IJN.S287784

Ejemplares similares